International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
- 29 October 2019
- journal article
- research article
- Published by Elsevier BV in The Lancet Haematology
- Vol. 6 (12), e638-e649
- https://doi.org/10.1016/s2352-3026(19)30166-8
Abstract
No abstract availableKeywords
Funding Information
- Austrian Science Fund (F4701-B20 and F4704-B20)
This publication has 30 references indexed in Scilit:
- The KITD816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the diseaseAllergy, 2014
- Comprehensive mutational profiling in advanced systemic mastocytosisBlood, 2013
- Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patientsJournal of Allergy and Clinical Immunology, 2009
- Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factorsBlood, 2009
- Mast cells and mastocytosisBlood, 2008
- Case-Control Cohort Study of Patients' Perceptions of Disability in MastocytosisPLOS ONE, 2008
- Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response CriteriaEuropean Journal of Clinical Investigation, 2007
- Systemic MastocytosisAnnual Review of Medicine, 2004
- Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosisLeukemia Research, 2001
- Response to Interferon Alfa-2b in a Patient with Systemic MastocytosisNew England Journal of Medicine, 1992